Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease.
Franceschino
Anna
A
University of Milano Bicocca, Section of Hematology, Ospedale S.Gerardo, Via Cadore 48, 20052 Monza, Italy.
Tornaghi
Lucia
L
Piazza
Rocco
R
Pogliani
Enrico
E
Gambacorti Passerini
Carlo
C
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D004334:Drug Administration Schedule; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D018365:Neoplasm, Residual / Q000188:drug therapy*; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction; D017211:Treatment Failure; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate